These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8420123)

  • 21. A link between cholesterol, synapse plasticity, degeneration and neurological disorders: reinvention or integration?
    Koudinov A
    Bioessays; 2003 Jul; 25(7):736-7; author reply 737. PubMed ID: 12815729
    [No Abstract]   [Full Text] [Related]  

  • 22. Is Alzheimer's disease preceded by neurodegeneration or cerebral hypoperfusion?
    de la Torre JC
    Ann Neurol; 2005 Jun; 57(6):783-4. PubMed ID: 15929049
    [No Abstract]   [Full Text] [Related]  

  • 23. Glutamic acid and Alzheimer's disease.
    Arias C; Becerra-García F; Tapia R
    Neurobiology (Bp); 1998; 6(1):33-43. PubMed ID: 9713830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect?
    Dickson DW
    J Clin Invest; 2004 Jul; 114(1):23-7. PubMed ID: 15232608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Episodic and semantic memory tasks activate different brain regions in Alzheimer disease.
    Starr JM; Loeffler B; Abousleiman Y; Simonotto E; Marshall I; Goddard N; Wardlaw JM
    Neurology; 2005 Jul; 65(2):266-9. PubMed ID: 16043797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease.
    Takeda T; Uchihara T; Arai N; Mizutani T; Iwata M
    Acta Neuropathol; 2009 Jan; 117(1):35-44. PubMed ID: 19002475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donepezil induces a cholinergic sprouting in basocortical degeneration.
    Ginestet L; Ferrario JE; Raisman-Vozari R; Hirsch EC; Debeir T
    J Neurochem; 2007 Jul; 102(2):434-40. PubMed ID: 17394553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of astroglial cell-derived nitric oxide and prostanoids in neurodegenerative disorders.
    Mollace V; Muscoli C; Nisticò G
    Funct Neurol; 1997; 12(3-4):199-203. PubMed ID: 9218977
    [No Abstract]   [Full Text] [Related]  

  • 29. [Perforant pathway degeneration as a system degeneration: secondary hippocampal degeneration in Alzheimer-type dementia].
    Mizutani T
    No To Shinkei; 1998 Oct; 50(10):895-905. PubMed ID: 9842548
    [No Abstract]   [Full Text] [Related]  

  • 30. Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease.
    McShea A; Wahl AF; Smith MA
    Med Hypotheses; 1999 Jun; 52(6):525-7. PubMed ID: 10459833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Capitalizing on cortical plasticity: influence of physical activity on cognition and brain function.
    Kramer AF; Erickson KI
    Trends Cogn Sci; 2007 Aug; 11(8):342-8. PubMed ID: 17629545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of neuronal degeneration and preventative approaches: quickening the pace of AD research.
    Mattson MP
    Neurobiol Aging; 1994; 15 Suppl 2():S121-5. PubMed ID: 7700435
    [No Abstract]   [Full Text] [Related]  

  • 33. Neurotransmitter regulation of neuronal outgrowth, plasticity and survival in the year 2001.
    Kater SB; Lipton SA
    Trends Neurosci; 1995 Feb; 18(2):71-2. PubMed ID: 7537415
    [No Abstract]   [Full Text] [Related]  

  • 34. The involvement of the ubiquitin system in Alzheimer's disease (review).
    Pallares-Trujillo J; Lopez-Soriano FJ; Argilés JM
    Int J Mol Med; 1998 Jul; 2(1):3-15. PubMed ID: 9854137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal degenerative mechanisms as clues to pathogenesis and treatment of Alzheimer's disease.
    Nixon RA
    Neurobiol Aging; 1994; 15 Suppl 2():S61-5. PubMed ID: 7700464
    [No Abstract]   [Full Text] [Related]  

  • 36. Deprivation-induced dendritic shrinkage might be oppositely affected by the expression of wild-type and mutated human amyloid precursor protein.
    Alpár A; Naumann N; Ueberham U; Arendt T; Gärtner U
    J Neurosci Res; 2009 Jun; 87(8):1813-22. PubMed ID: 19170186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A network dysfunction perspective on neurodegenerative diseases.
    Palop JJ; Chin J; Mucke L
    Nature; 2006 Oct; 443(7113):768-73. PubMed ID: 17051202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tauopathy and Alzheimer disease: a full degenerating process].
    Buée L; Delacourte A
    Psychol Neuropsychiatr Vieil; 2006 Dec; 4(4):261-73. PubMed ID: 17194646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy.
    Kuipers SD; Bramham CR
    Curr Opin Drug Discov Devel; 2006 Sep; 9(5):580-6. PubMed ID: 17002218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuro-modulation, aminergic neuro-disinhibition and neuro-degeneration. Draft of a comprehensive theory for Alzheimer disease.
    Schmitt HP
    Med Hypotheses; 2005; 65(6):1106-19. PubMed ID: 16125326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.